Drug-Induced Alopecia Areata From Upadacitinib

    August 2024 in “ Cureus ”
    Alexander H Chang, Nicholas Brownstone, Sylvia Hsu
    Studysummary In this case report, a 55-year-old woman developed alopecia areata approximately one year into her treatment with upadacitinib for atopic dermatitis, raising questions about a potential drug-induced link that has not been reported before.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on assets.cureus.com →
    Discuss this study in the Community →

    Research cited in this study 10

    1. Successful Treatment of Severe Atopic Dermatitis and Alopecia Universalis With Upadacitinib in a 29-Year-Old Male Patient Journal of Allergy and Clinical Immunology Global · 2024
    2. Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series Clinical, cosmetic and investigational dermatology · 2024
    3. Selective JAK 1 Inhibition With Upadacitinib as a Potential Treatment for Coexistent Severe Atopic Dermatitis and Alopecia Areata Anais Brasileiros de Dermatologia · 2024
    4. A Cross-Sectional Analysis of Medications Used by Patients Reporting Alopecia Areata on the FDA Adverse Events Reporting System International Journal of Dermatology · 2024
    5. Upadacitinib in Concurrent Crohn's Disease, Atopic Dermatitis, and Alopecia Areata: A Case Report Journal of the European Academy of Dermatology and Venereology · 2023
    6. Drug-Induced Alopecia Areata: A Systematic Review Journal of the American Academy of Dermatology · 2023
    7. Upadacitinib for Management of Recalcitrant Alopecia Areata: A Retrospective Case Series JAAD case reports · 2023
    8. Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib: A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata Dermatology and therapy · 2023
    9. Successful Treatment of Concomitant Alopecia Universalis and Crohn's Disease with Upadacitinib: A Case Report SAGE Open Medical Case Reports · 2023
    10. Upadacitinib for the Treatment of Alopecia Areata and Severe Atopic Dermatitis in a Pediatric Patient: A Case Report SAGE open medical case reports · 2022

    Related research 1

    1. Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child International journal of research in dermatology · 2019